Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02129426 · ClinicalTrials.gov registry record · NA
Comparison of Outcomes During MRI Sedation With Midazolam-dexmedetomidine Versus Ketamine-dexmedetomidine
A NA study, sponsored by University of Louisville.
- Terminated
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT02129426 is a NA study that was terminated before completion, run by University of Louisville. The registered enrollment target is 21 participants.
The verdict
NCT02129426, a NA study, was terminated before completion, sponsored by University of Louisville.
- TERMINATED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
This study will compare 2 different sedation drugs (Ketamine and Midazolam) when they are used with another sedating medicine called Dexmedetomidine for MRI sedation. This study hopes to measure the impact each drug has on what happens during and after MRI sedation with Dexmedetomidine
Interventions
- DRUG Ketamine
- DRUG Midazolam
- DRUG Dexmedetomidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2014-08 |
| Est. Completion | 2018-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02129426
The ClinicalTrials.gov registry entry for NCT02129426 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Ketamine is the first listed.
NCT02129426 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02129426 about?
NCT02129426 is a clinical study titled "Comparison of Outcomes During MRI Sedation With Midazolam-dexmedetomidine Versus Ketamine-dexmedetomidine". This study will compare 2 different sedation drugs (Ketamine and Midazolam) when they are used with another sedating medicine called Dexmedetomidine for MRI sedation. This study hopes to measure the impact each drug has on what happens during and after MRI sedation with Dexmedetomidine
What is the current status of trial NCT02129426?
This trial is currently terminated. It is a NA study. The enrollment target is 21 participants. The study started on 2014-08. Estimated completion is 2018-03.
What interventions are being tested in trial NCT02129426?
The interventions under investigation include: Ketamine (DRUG), Midazolam (DRUG), Dexmedetomidine (DRUG).
Who is sponsoring clinical trial NCT02129426?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.